EPS

ArcelorMittal publishes revised analyst model per new segmental reporting

Retrieved on: 
Wednesday, March 27, 2024

As announced with ArcelorMittal’s (‘the Company’) fourth quarter 2023 financial results, the Company has amended its presentation of reportable segments and EBITDA.

Key Points: 
  • As announced with ArcelorMittal’s (‘the Company’) fourth quarter 2023 financial results, the Company has amended its presentation of reportable segments and EBITDA.
  • India is a high growth vector of the Company, with our assets well-positioned to grow with the domestic market;
    A new ‘Sustainable Solutions’ segment is composed of a number of high-growth, niche, capital light businesses, playing an important role in supporting climate action (including renewables, special projects and construction business).
  • Previously reported within the Europe segment, this is a growth vector of the Company and represents businesses employing over 12,000 people at more than 260 commercial and production sites across 60+ countries;
    Following the sale of the Company’s operations in Kazakhstan, the remaining parts of the former ‘ACIS’ segment have been assigned to ‘Others’; there are no changes to the ‘Brazil’ and ‘Mining’ segments.
  • The following periods: FY 2021, FY 2022 and FY 2023 and all four quarters of 2023 - have been recast in the Company’s published analyst model which can be viewed here: https://corporate.arcelormittal.com/investors/results
    In addition, the Company has included key reconciliations of net income/ (loss) to EBITDA and adjusted net income and adjusted EPS as well as provided historic key performance indicators for its three key JVs: AMNS India, AMNS Calvert and VAMA.

Direct Digital Holdings Alert – Johnson Fistel, LLP Encourages Shareholders to Contact the Firm Following the DRCT Earnings Report

Retrieved on: 
Tuesday, March 26, 2024

SAN DIEGO, March 26, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of securities laws by Direct Digital Holdings, Inc. (NASDAQ: DRCT).

Key Points: 
  • SAN DIEGO, March 26, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of securities laws by Direct Digital Holdings, Inc. (NASDAQ: DRCT).
  • If you have purchased Direct Digital Holdings securities and have experienced losses, we encourage you to join our investigation to potentially make claims and recover under federal securities laws.
  • What if I purchased Direct Digital Holdings securities?
  • Following this news, Direct Digital Holdings stock was trading 48% lower in after-hours trading on March 26, 2024.

Concentrix Reports First Quarter 2024 Results

Retrieved on: 
Tuesday, March 26, 2024

First Quarter Fiscal 2024 Highlights:

Key Points: 
  • First Quarter Fiscal 2024 Highlights:
    Revenue was $2,402.7 million, up 46.8% from the prior year first quarter compared with $1,636.4 million in the prior year first quarter.
  • The following statements are based on the Company’s current expectations for the second quarter of fiscal 2024 and the full year fiscal 2024.
  • Second Quarter Fiscal 2024 Expectations:
    Second quarter reported revenue is expected to be in the range of $2.325 billion to $2.372 billion.
  • The Company will host a conference call for investors to review its first quarter fiscal 2024 results today at 5:00 p.m. (ET)/2:00 p.m. (PT).

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Innodata, Fox Factory, Lantronix, and Palo Alto Networks and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, March 26, 2024

Innodata also stopped disclosing its Research and Development spend after the first quarter of 2021.

Key Points: 
  • Innodata also stopped disclosing its Research and Development spend after the first quarter of 2021.
  • On this news, the price of Innodata common stock declined by $3.74 per share, or approximately 30.5%, on February 15, 2024.
  • The complaint further alleges that when these misleading statements and omissions about Fox Factory’s business reached the market, investors were harmed significantly.
  • For more information on the Palo Alto Networks class action go to: https://bespc.com/cases/PANW

InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024

Retrieved on: 
Tuesday, March 26, 2024

TEL AVIV, Israel and MIAMI, March 26, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that an abstract of the one-year outcomes from its C-GUARDIANS IDE clinical trial of the CGuard™ Prime Carotid Stent System for the treatment of carotid artery stenosis has been accepted for presentation at the Leipzig Interventional Course (LINC) 2024, which is being held May 28-31, in Leipzig, Germany.

Key Points: 
  • TEL AVIV, Israel and MIAMI, March 26, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that an abstract of the one-year outcomes from its C-GUARDIANS IDE clinical trial of the CGuard™ Prime Carotid Stent System for the treatment of carotid artery stenosis has been accepted for presentation at the Leipzig Interventional Course (LINC) 2024, which is being held May 28-31, in Leipzig, Germany.
  • Chris Metzger, M.D., System Vascular Chief at Ohio Health, and lead investigator of the C-Guardians trial
    Marvin Slosman, chief executive officer of InspireMD, stated, “At last year’s VIVA and VEITH conferences in November, Dr. Metzger, principal investigator for the C-GUARDIANS trial, presented positive 30-day follow-up data from the trial which demonstrated a DSMI1 rate of just 0.95% in the Intent-To-Treat (ITT) analysis population, and 0.63% in the per-protocol (PP) analysis population.
  • We are very excited to announce today that an abstract of the 12-month outcomes data from this important trial has been accepted for presentation at the upcoming LINC 2024 conference, which is among the most influential and widely attended meetings focused on vascular intervention.
  • We are optimistic that the results will show a similar level of neuroprotection, which may support a Premarket Approval Application (PMA) later this year and allow us to prepare for a commercial launch of CGuard Prime in the U.S. in the first half of 2025, if approved.”

C3is Inc. reports Revenue of $13.8 million, Net Income of $5.6 million and $0.25 earnings per diluted share for the fourth quarter of 2023, and financial and operating results for the quarter and twelve months ended December 31, 2023

Retrieved on: 
Tuesday, March 26, 2024

Voyage revenues of $28.7 million for the twelve months ended December 31, 2023, corresponding to a daily TCE1 of $23,453.

Key Points: 
  • Voyage revenues of $28.7 million for the twelve months ended December 31, 2023, corresponding to a daily TCE1 of $23,453.
  • Our Company generated a net income of $9.3 million for the twelve months ended December 31, 2023, and a net income of $5.6 million for the three months ended December 31, 2023.
  • 69.7% increase in Net Income to $5.6 million for the three months ended December 31, 2023, from $3.3 million for the three months ended September 30, 2023.
  • 45.3% increase in EBITDA2 to $7.7 million for the three months ended December 31, 2023, from $5.3 million for the three months ended September 30, 2023.

Cognyte Reports Fourth Quarter and Fiscal Year Ended January 31, 2024 Financial Results

Retrieved on: 
Tuesday, April 9, 2024

“The fourth quarter was a strong finish to a productive year for Cognyte,” said Elad Sharon, Cognyte’s chief executive officer.

Key Points: 
  • “The fourth quarter was a strong finish to a productive year for Cognyte,” said Elad Sharon, Cognyte’s chief executive officer.
  • Our customers are facing evolving challenges and recognize the strength of our differentiated technology and the value it delivers.
  • “We have leverage in our financial model and are focusing on driving margin expansion.
  • ET to discuss our results for the three months and year ended January 31, 2024.

Global Market for Molded Fiber Packaging 2024-2035, Featuring 70+ Key Players Including HZ Green Pulp, Omni-Pac, PulPac, Sabert Corporation, Tanbark Molded Fiber Products and TekniPlex - ResearchAndMarkets.com

Retrieved on: 
Monday, April 8, 2024

As a green and sustainable packaging materials, molded fiber, also known as molded pulp, has increased in commercial use as a replacement for single-use plastics.

Key Points: 
  • As a green and sustainable packaging materials, molded fiber, also known as molded pulp, has increased in commercial use as a replacement for single-use plastics.
  • Molded fiber packaging (MFP), traditionally used for packaging dunnage, egg boxes, and cartons, is finding increasing applications in primary and secondary packaging as a sustainable alternative to plastics.
  • The Global Market for Molded Fiber Packaging 2024-2035 offers an in-depth analysis of the latest trends, innovations, and opportunities in this rapidly growing industry.
  • Companies profiled include HZ Green Pulp, Omni-Pac, PulPac, Sabert Corporation, Tanbark Molded Fiber Products and TekniPlex.

Security Systems Provider Scales for Growth with Award-Winning UKG Ready Suite

Retrieved on: 
Monday, April 8, 2024

UKG, a leading provider of HR, payroll, workforce management, and culture solutions for all people, today announced that EPS Security, a family-owned security systems provider and a UKG customer for nearly a decade, is leveraging the AI-powered UKG Ready suite to build a great place to work for frontline employees and support its long-term growth plans.

Key Points: 
  • UKG, a leading provider of HR, payroll, workforce management, and culture solutions for all people, today announced that EPS Security, a family-owned security systems provider and a UKG customer for nearly a decade, is leveraging the AI-powered UKG Ready suite to build a great place to work for frontline employees and support its long-term growth plans.
  • EPS Security employs 240 people, most of whom are technicians working in the field to install and service equipment like burglar and fire alarms, access control, and video systems.
  • “A few years ago, we added payroll to our UKG Ready suite, and the results have been tremendous,” said Wolfsen.
  • “By empowering employees with innovative technology such as UKG Ready, organizations not only enhance efficiency and innovation but also foster a culture of continuous improvement.”

Alger Expands High-Conviction Growth Equity Lineup with the Launch of the Alger AI Enablers & Adopters and Alger Concentrated Equity Strategies

Retrieved on: 
Monday, April 8, 2024

NEW YORK, April 8, 2024 /PRNewswire-PRWeb/ -- Fred Alger Management, LLC ("Alger"), a privately held $25.7 billion growth equity investment manager, today announced the launch of two high-conviction portfolios: Alger AI Enablers & Adopters and Alger Concentrated Equity. Both strategies are available as ETFs, mutual funds, and separate accounts.

Key Points: 
  • NEW YORK, April 8, 2024 /PRNewswire-PRWeb/ -- Fred Alger Management, LLC ("Alger"), a privately held $25.7 billion growth equity investment manager, today announced the launch of two high-conviction portfolios: Alger AI Enablers & Adopters and Alger Concentrated Equity.
  • Alger AI Enablers & Adopters, managed by Patrick Kelly, CFA, is a focused portfolio of companies actively involved in developing and implementing Artificial Intelligence (AI) technologies.
  • In our view, organizations that embrace AI technologies better position themselves to drive sustainable growth in the digital age.
  • Alger Concentrated Equity is a focused portfolio of 20-30 stocks representing the highest conviction investment ideas of portfolio manager Dr. Ankur Crawford.